Table of Contents
Chapter 1. Global In Vivo Toxicology Market Executive Summary
1.1. Global In Vivo Toxicology Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Test Type
1.3.3. By Testing Facility
1.3.4. By Toxicity End Point
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global In Vivo Toxicology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global In Vivo Toxicology Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Drug Development
3.1.2. Regulatory Requirements
3.1.3. Technological Advancements
3.2. Market Challenges
3.2.1. Ethical and Animal Welfare Concerns
3.3. Market Opportunities
3.3.1. Growing Biotechnology Sector
3.3.2. Rising Focus on Personalized Medicine
Chapter 4. Global In Vivo Toxicology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global In Vivo Toxicology Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global In Vivo Toxicology Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Instruments
5.2.2. Consumables
Chapter 6. Global In Vivo Toxicology Market Size & Forecasts by Test Type 2022-2032
6.1. Segment Dashboard
6.2. Global In Vivo Toxicology Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Acute
6.2.2. Sub-acute
6.2.3. Sub-chronic
6.2.4. Chronic test type
Chapter 7. Global In Vivo Toxicology Market Size & Forecasts by Testing Facility 2022-2032
7.1. Segment Dashboard
7.2. Global In Vivo Toxicology Market: Testing Facility Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Outsourced testing facility
7.2.2. In-house testing facility
Chapter 8. Global In Vivo Toxicology Market Size & Forecasts by Toxicity End Point 2022-2032
8.1. Segment Dashboard
8.2. Global In Vivo Toxicology Market: Toxicity End Point Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Immunotoxicity
8.2.2. Systemic toxicity
8.2.3. Carcinogenicity
8.2.4. Genotoxicity
8.2.5. Developmental & reproductive toxicity (DART)
8.2.6. Other toxicity endpoints
Chapter 9. Global In Vivo Toxicology Market Size & Forecasts by End User 2022-2032
9.1. Segment Dashboard
9.2. Global In Vivo Toxicology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Academic and Research Institutes
9.2.2. Pharmaceutical & Biotechnology Companies
9.2.3. Contract Research Organizations
9.2.4. Other End Users
Chapter 10. Global In Vivo Toxicology Market Size & Forecasts by Region 2022-2032
10.1. North America In Vivo Toxicology Market
10.1.1. U.S. In Vivo Toxicology Market
10.1.1.1. Product breakdown size & forecasts, 2022-2032
10.1.1.2. Test Type breakdown size & forecasts, 2022-2032
10.1.1.3. Testing Facility breakdown size & forecasts, 2022-2032
10.1.1.4. Toxicity End Point breakdown size & forecasts, 2022-2032
10.1.1.5. End User breakdown size & forecasts, 2022-2032
10.1.2. Canada In Vivo Toxicology Market
10.2. Europe In Vivo Toxicology Market
10.2.1. U.K. In Vivo Toxicology Market
10.2.2. Germany In Vivo Toxicology Market
10.2.3. France In Vivo Toxicology Market
10.2.4. Spain In Vivo Toxicology Market
10.2.5. Italy In Vivo Toxicology Market
10.2.6. Rest of Europe In Vivo Toxicology Market
10.3. Asia-Pacific In Vivo Toxicology Market
10.3.1. China In Vivo Toxicology Market
10.3.2. India In Vivo Toxicology Market
10.3.3. Japan In Vivo Toxicology Market
10.3.4. Australia In Vivo Toxicology Market
10.3.5. South Korea In Vivo Toxicology Market
10.3.6. Rest of Asia Pacific In Vivo Toxicology Market
10.4. Latin America In Vivo Toxicology Market
10.4.1. Brazil In Vivo Toxicology Market
10.4.2. Mexico In Vivo Toxicology Market
10.4.3. Rest of Latin America In Vivo Toxicology Market
10.5. Middle East & Africa In Vivo Toxicology Market
10.5.1. Saudi Arabia In Vivo Toxicology Market
10.5.2. South Africa In Vivo Toxicology Market
10.5.3. Rest of Middle East & Africa In Vivo Toxicology Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Charles River Laboratories
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. The Jackson Laboratory
11.3.3. Envigo
11.3.4. Taconic Biosciences, Inc.
11.3.5. JANVIER LABS
11.3.6. Thermo Fisher Scientific
11.3.7. Danaher Corporation
11.3.8. Waters Corporation
11.3.9. Agilent Technologies
11.3.10. Shimadzu Corporation
11.3.11. Bruker Corporation
11.3.12. PerkinElmer
11.3.13. Merck KGaA
11.3.14. GE Healthcare
11.3.15. Bio-Rad Laboratories
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes